RxDoctor Payments Data

David Asmuth

Infectious Disease · Sacramento, CANPI 1972573046

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $200,978 of the $316,090 with a category attached, or 63.6%. 8 manufacturers reported payments, led by Viiv Healthcare Company at 48.2% of the total. Reporting peaked in 2019 at $144,962 and has fallen 93.7% since, to $9,182 in 2025. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$316,090in general payments, 2019–2025

Across 329 payments — averaging $960.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$152K
  • Merck$55K
  • Napo Pharmaceuticals Inc$53K
  • Gilead$44K
  • Janssen Products, LP$11K
  • Theratechnologies Inc.$884
  • plus $27 from 2 others
$611,519in research payments, 2019–2025

Across 158 payments — averaging $3870.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$508K
  • Merck$66K
  • Viiv Healthcare Company$36K
  • Pfizer$2K

What the payments were for

  • Consulting fees$85,30527%
  • Speaking & faculty fees$200,97864%
  • Travel & lodging$23,0837%
  • Food & beverage$6,6932%
  • Education$310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$316,090 in reported general payments places this provider in the 95th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Other infectious disease in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →